Slovakia Authorized Ivermectin: Then What Happened?

Slovakia Authorized Ivermectin Then What Happened

TrialSite was able to touch base again with research Ondrej Halgas with the University of Toronto. Back in late January of this year, we reported that Slovakia was the first EU-based nation to formally authorize the use of ivermectin for both prophylaxis and treatment for COVID-19 patients. A biomedical researcher, Dr. Halgas has been active in the Slovakian community and provided important insight for that update. TrialSite caught up again with Halgas to learn more about how the administration of ivermectin in Slovakia was coming along. On March 23, TrialSite did report on the situation based on another expat interview and updates from various press sources.  There were reports that at least by late January and early February, many Slovakians were mail ordering supplies of ivermectin, which were stopped at customs, never released to the individuals that made the order. Halgas reports that supplies of ivermectin have improved somewhat and that depending on pharmacy, there was more access, but nowhere near enough to satisfy, the demand based on the recent COVID-19 spike in this part of Europe. In a dynamic and unfolding situation, now as more supply found its way into the country (...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee